Summary
The amount of antihypertensive and antidiabetic drugs based of defined daily doses per 1000 inhabitants per day varies two to three fold between Northern Ireland, Norway, and Sweden. We explored whether variations based on the universally applied defined daily doses might be accounted for by national differences in the actual average prescribed daily doses. Use of prescribed daily doses for antihypertensive drugs resulted in Northern Irish and Norwegian consumption figures which were respectively 40 and 21% lower than the Swedish one, compared to 38 and 25% when defined daily doses were used. The effect of population age-sex differences on the gross defined daily doses per 1000 inhabitants per day figures was determined by applying the Northern Irish or Norwegian age-sex group proportions to Swedish age-sex specific sales data. Taking population differences into account would have resulted in antihypertensive drug use being 21 rather than 38% less in Northern Ireland and 18 rather than 25% less in Norway. Also adjustment for prescribed daily doses left an unexplained difference of 23% between Sweden and Northern Ireland and 14% between Sweden and Norway. For oral antidiabetics use of prescribed daily doses resulted in a Northern Irish — Swedish difference of 62% compared to 67% when defined daily doses were used. Simultaneous adjustment for population differences and prescribed to defined daily dose variations left a 52% difference.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergman U, Elmes P, Halse M, Halvorsen T, Hood M, Lunde PKM, Sjöqvist F, Wade OL, Westerholm B (1975) The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway, and Sweden. Europ J Clin Pharmacol 8: 83–89
Bergman U (1979) International comparisons of drug utilization: Use of antidiabetic drugs in seven European countries. In: WHO Regional Publications. European Series Copenhagen 8: 147–162
Baksaas I (1978) Antihypertensive drugs. In: Duchene-Marullaz P (ed). Advances in pharmacology and therapeutics, vol 6. Clinical pharmacology. Pergamon Press Oxford New York, pp 133–142
Nordic Council on Medicines, Nordic statistics on medicines 1975–1977. Statistical reports of the Nordic countries 35–36. Helsingfors 1979, Oslo 1979
Nordic Council on Medicines. Nordic statistics on medicines 1978–1980. NLN Publication no. 8–9, Uppsala 1982
Lunde PKM, Baksaas I, Halse M, Halvorsen T, Stromnes B, Öydvin K (1979) The methodology of drug utilization studies. In: WHO Regional Publications. European Series Copenhagen 8: 17–28
Westerholm B (1979) Data collection in Sweden. Ibid, pp 73–82
Halvorsen IK, Halse M, Lunde PKM, Baksaas I, Strömnes B, Öydvin K (1979) Data collection in Norway. Ibid, pp 59–72
McDevitt DG, McMeekin C (1979) Data collection in Northern Ireland. Ibid, pp 103–111
Griffiths K, McDevitt DG (1983) A community pharmacy-based survey of antihypertensive and antidiabetic drug dosages in Northern Ireland. J Clin Hosp Pharm 8: 115–124
Agenäs I, Jacobsson M, Kristoferson K (1980) Diagnos Receptundersökningen. Svensk Farmaceutisk Tidskrift 84: 321
Bergman U, Manell P, Wessling A (1983) Treatment of hypertionsion in the elderly. Patterns of drug utilization in Sweden. In: National Board of Health and Welfare, Drug Information Committée Sweden, Uppsala 1983: 4
Baksaas I, Fugelli P, Halvorsen IK, Lunde PKM, Naess K (1978) Prescription of hypotensives in general practice: A study of 4 Norwegian counties in October 1975. Eur J Clin Pharmacol 14: 309–317
Baksaas I (1978) Drug treatment with hypotensives with special emphasis on the relationship between prescribed and defined daily doses. Medd Norsk Farm Selsk 40: 69–84
Holmen J (1983) Trökket, trimmen og tablettan. En analyse av blodtrykksbehandlingen i Nord-Tröndelag 1980–1981. Oslo: Gruppe for helsetjenesteforskning, SIFF Rapport no. 11
Bergman U (1978) Studies of drug utilization. Clinical pharmacological and epidemiological aspects. Thesis Stockholm: Karolinska institutet
Baksaas I (1980) Drug utilization studies — at overall, prescription, and patient levels. Thesis, Oslo: Ullevål hospital, Central laboratory
Berman U (1978) Utilization of antidiabetic drugs in the island of Gotland, Sweden: Agreement between wholesale figures and prescription data. Eur J Clin Pharmacol 14: 213–220
National Corporation of Swedish Pharmacies (Apoteksbolaget) Svensk Läkemedelsstatistik 1982
King DT, Griffiths K, Reilly PM, Merrett TD (1982) Psychotropic drug use in Northern Ireland 1966–80: Prescribing trends, inter and intra-regional comparisons and relationship to demographic and socioeconomic variables. Psychol Med 12: 819–833
Baksaas I (1984) Patterns in drug-utilization — national and international aspects: Antihypertensive drugs. Acta Med Scand 683 [Suppl]: 59–66
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
WHO Drug Utilization Research Group (DURG)., Griffiths, K., McDevitt, D.G. et al. Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol 29, 1–8 (1985). https://doi.org/10.1007/BF00547360
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00547360